OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
781358

Platz Co Ltd

Medical Equipment, Supplies & DistributionVerified

PLATZ maintains a liquidity position with a current ratio of 2.32, indicating a moderate ability to cover short-term obligations, supported by cash and equivalents of ¥1.73 billion. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity risk. The debt-to-equity ratio of 0.69 suggests a balanced capital structure, with long-term debt of ¥2.13 billion and total equity of ¥3.10 billion. Profitability metrics show a return on equity of 6.23% and a return on assets of 3.09%, both below the industry median for medical equipment firms. Operating income of ¥183.5 million and net income of ¥192.9 million reflect modest profitability, with gross profit of ¥2.52 billion representing 30% of revenue. The company's revenue is concentrated in its Medical Care Nursing Electric Bed segment, which accounts for the majority of its ¥8.42 billion in revenue. Geographic exposure is primarily domestic, with limited details on international market share. The Fitness segment, operating a women-only gym, contributes a smaller portion of revenue. Growth trajectory is constrained, with no significant revenue growth reported in the latest period. The company's capital expenditure of ¥215.6 million reflects ongoing investment in operations, but free cash flow of ¥65.3 million is limited, suggesting capacity for reinvestment is constrained. Risk factors include liquidity concerns due to negative net cash and a medium liquidity risk rating. Dilution risk is low, with no near-term pressure from share issuance or convertible debt. However, the company's reliance on a single product line and domestic market exposure could pose operational risks. Recent filings and transcripts indicate no major strategic shifts or capital-raising events. The company continues to focus on its core electric bed business, with no disclosed plans for expansion into new product lines or geographic regions.

30-day price · 7813(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyPlatz Co Ltd
Ticker7813.T
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
AI analysis

Business. PLATZ Co., Ltd. designs, develops, and sells electric beds for medical and nursing care, operating through two segments: Medical Care Nursing Electric Bed and Fitness, with products sold in domestic and international markets.

Classification. PLATZ is classified under the Healthcare Services & Equipment business sector, with a 0.92 confidence level in the Medical Equipment, Supplies & Distribution industry.

PLATZ maintains a liquidity position with a current ratio of 2.32, indicating a moderate ability to cover short-term obligations, supported by cash and equivalents of ¥1.73 billion. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity risk. The debt-to-equity ratio of 0.69 suggests a balanced capital structure, with long-term debt of ¥2.13 billion and total equity of ¥3.10 billion. Profitability metrics show a return on equity of 6.23% and a return on assets of 3.09%, both below the industry median for medical equipment firms. Operating income of ¥183.5 million and net income of ¥192.9 million reflect modest profitability, with gross profit of ¥2.52 billion representing 30% of revenue. The company's revenue is concentrated in its Medical Care Nursing Electric Bed segment, which accounts for the majority of its ¥8.42 billion in revenue. Geographic exposure is primarily domestic, with limited details on international market share. The Fitness segment, operating a women-only gym, contributes a smaller portion of revenue. Growth trajectory is constrained, with no significant revenue growth reported in the latest period. The company's capital expenditure of ¥215.6 million reflects ongoing investment in operations, but free cash flow of ¥65.3 million is limited, suggesting capacity for reinvestment is constrained. Risk factors include liquidity concerns due to negative net cash and a medium liquidity risk rating. Dilution risk is low, with no near-term pressure from share issuance or convertible debt. However, the company's reliance on a single product line and domestic market exposure could pose operational risks. Recent filings and transcripts indicate no major strategic shifts or capital-raising events. The company continues to focus on its core electric bed business, with no disclosed plans for expansion into new product lines or geographic regions.
Key takeaways
  • PLATZ operates in a niche medical equipment market with limited diversification.
  • The company's liquidity position is moderate, with a current ratio of 2.32 but negative net cash after debt.
  • Profitability is below industry medians, with ROE of 6.23% and ROA of 3.09%.
  • Revenue is heavily concentrated in the domestic medical bed segment, with limited international exposure.
  • Growth is constrained by limited free cash flow and modest operating margins.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyJPY
Revenue$8.42B
Gross profit$2.52B
Operating income$183.5M
Net income$193.0M
R&D
SG&A
D&A
SBC
Operating cash flow$219.0M
CapEx-$215.6M
Free cash flow$65.3M
Total assets$6.25B
Total liabilities$3.15B
Total equity$3.10B
Cash & equivalents$1.73B
Long-term debt$2.13B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$3.10B
Net cash-$402.0M
Current ratio2.3
Debt/Equity0.7
ROA3.1%
ROE6.2%
Cash conversion1.1%
CapEx/Revenue-2.6%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Healthcare Services & Equipment · cohort 5 companies
Metric7813Activity
Op margin2.2%13.3% medp25 5.9% · p75 13.5%bottom quartile
Net margin2.3%8.6% medp25 2.7% · p75 12.7%bottom quartile
Gross margin29.9%64.0% medp25 60.1% · p75 65.6%bottom quartile
R&D / revenue6.9% medp25 6.7% · p75 7.1%
CapEx / revenue-2.6%3.0% medp25 2.7% · p75 4.5%bottom quartile
Debt / equity69.0%69.3% medp25 63.4% · p75 74.5%below median
Observations
IR observations
Last actual EPS54.71 JPY
Last actual revenue8,422,000,000 JPY
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 07:08 UTC#d066d59c
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 07:10 UTCJob: b2d326f6